LLY vs UNH
By Alex · Tickerpine
Eli Lilly and Company vs UnitedHealth Group Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | UNH |
|---|---|---|
| Price | $1,220.28 | $405.59 |
| Market cap | $1.09T | $364.06B |
| P/E ratio | 41.0 | 26.0 |
| ROE | 102.29% | 14.15% |
| Profit margin | 33.53% | 3.14% |
| Revenue growth | 47.70% | 0.40% |
| Dividend yield | 0.57% | 2.29% |
| Beta | 0.51 | 0.63 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs UNH in plain English
- LLY is the bigger company — about 3.0× the market cap of UNH.
- UNH is cheaper on earnings (P/E 26.0 vs 41.0).
- LLY earns a higher return on equity (102% vs 14%).
- LLY is growing revenue faster (48% vs 0%).
- UNH has the higher dividend yield (2.29% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.